Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): An Asian multinational study

臺大醫院;臺大醫院-泌尿部;Ye, D.D.YeAhn, H.H.AhnPu, Y-S.Y-S.PuHan, W.W.HanXie, L-P.L-P.XieHuang, S-P.S-P.HuangWu, H-C.H-C.WuMa, L.L.MaQi, J.J.QiZhou, F.F.ZhouSun, G.G.SunChen, L.L.ChenXue, B.B.XueYamada, S.S.YamadaSaito, M.M.SaitoSuga, K.K.SugaSun, Y.Y.Sun蒲永孝2017-09-272018-07-112017-09-272018-07-112016http://ntur.lib.ntu.edu.tw//handle/246246/283644[SDGs]SDG3Efficacy, safety and pharmacokinetics (PK) of enzalutamide (ENZ) vs placebo (PL) in chemotherapy-naive patients (pts) with progressive metastatic castration-resistant prostate cancer (mCRPC): An Asian multinational study